OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
44
Results
Show all
Save search
Copy query
Show results for
Unknown
(43)
Metabolomics
(1)
Repository
MetaboLights
(1)
Technology Type
Mass spectrometry
(1)
Instrument Platform
Liquid Chromatography MS - positive - reverse phase
(1)
Publication Date
2021
(1)
CHEBI ID
CHEBI:13248
(1)
CHEBI:15841
(1)
CHEBI:16670
(1)
CHEBI:17102
(1)
CHEBI:17761
(1)
CHEBI:18000
(1)
CHEBI:18059
(1)
CHEBI:18379
(1)
CHEBI:18946
(1)
CHEBI:19254
(1)
CHEBI:19255
(1)
CHEBI:22063
(1)
CHEBI:22160
(1)
CHEBI:22315
(1)
CHEBI:22327
(1)
CHEBI:22580
(1)
CHEBI:22682
(1)
CHEBI:22712
(1)
CHEBI:22712; CHEBI:18379
(1)
CHEBI:22715
(1)
CHEBI:22715; CHEBI:23003
(1)
CHEBI:22715; CHEBI:35813
(1)
CHEBI:22720
(1)
CHEBI:22723
(1)
CHEBI:22726
(1)
CHEBI:22727
(1)
CHEBI:22743
(1)
CHEBI:22888
(1)
CHEBI:22951
(1)
CHEBI:23000
(1)
Metabolite Name
1,2,4-triazines
(1)
1,4-benzodiazepines
(1)
1-benzopyrans
(1)
1-hydroxy-2-unsubstituted benzenoids
(1)
1-hydroxy-4-unsubstituted benzenoids
(1)
2,6-dimethyl-3-benzazocines
(1)
2-arylbenzofuran flavonoids
(1)
2-benzimidazolylcarbamic acid esters
(1)
2-benzopyrans
(1)
3,4-dihydrocoumarins
(1)
4-quinolinemethanols
(1)
5'-deoxy-5'-thionucleosides
(1)
5'-deoxyribonucleosides
(1)
8-hydroxyquinolines
(1)
Acrylic acids and derivatives
(1)
Alcohols and polyols
(1)
Alkali metal chlorates
(1)
Alkali metal sulfates
(1)
Alloxazines and isoalloxazines
(1)
Amines
(1)
Amino acids, peptides, and analogues
(1)
Aminophenyl ethers
(1)
Aminopiperidines
(1)
Aminopyridines and derivatives
(1)
Aminoquinolines and derivatives
(1)
Androstane steroids
(1)
Anilides
(1)
Aniline and substituted anilines
(1)
Anisoles
(1)
Anthracenes
(1)
Release Date
2024
(10)
2021
(6)
2023
(5)
2020
(5)
2022
(4)
2025
(3)
2026
(2)
2017
(2)
2016
(2)
2015
(2)
2018
(1)
2013
(1)
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
PM
2.5
impairs macrophage functions to exacerbate pneumococcus-induced pulmonary pathogenesis.
Not available
S-EPMC7409448
|
biostudies-literature
Cite
GLP-1 RAs and Cardiovascular and Kidney Outcomes by Body Mass Index in Type 2 Diabetes.
Not available
S-EPMC12418133
|
biostudies-literature
Cite
Treatment of complicated urinary tract infection and acute pyelonephritis by short-course intravenous levofloxacin (750 mg/day) or conventional intravenous/oral levofloxacin (500 mg/day): prospective, open-label, randomized, controlled, multicenter, non-inferiority clinical trial.
Not available
S-EPMC5321781
|
biostudies-literature
Cite
Repairing Interfacial Defects in Self-Assembled Monolayers for High-Efficiency Perovskite Solar Cells and Organic Photovoltaics through the SAM@Pseudo-Planar Monolayer Strategy.
Not available
S-EPMC11423173
|
biostudies-literature
Cite
Cyclical palmitoylation regulates TLR9 signalling and systemic autoimmunity in mice.
Not available
S-EPMC10762000
|
biostudies-literature
Cite
A targeted next-generation sequencing in the molecular risk stratification of adult acute myeloid leukemia: implications for clinical practice.
Not available
S-EPMC5313641
|
biostudies-literature
Cite
Lonicerin promotes wound healing in diabetic rats by enhancing blood vessel regeneration through Sirt1-mediated autophagy.
Not available
S-EPMC10943091
|
biostudies-literature
Cite
LPS receptor subunits have antagonistic roles in epithelial apoptosis and colonic carcinogenesis.
Not available
S-EPMC4563778
|
biostudies-literature
Cite
Determination of NUDT15 variants by targeted sequencing can identify compound heterozygosity in pediatric acute lymphoblastic leukemia patients.
Not available
S-EPMC7463237
|
biostudies-literature
Cite
Suppression of ZEAXANTHIN EPOXIDASE 1 restricts stripe rust growth in wheat.
Not available
S-EPMC10504589
|
biostudies-literature
Cite
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets